These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 8259095)
1. What is the prognostic value of osteomedullary uptake on MIBG scan in neuroblastoma patients under one year of age? Labreveux de Cervens C; Hartmann O; Bonnin F; Couanet D; Valteau-Couanet D; Lumbroso J; Behar C; Martelli H; Lemerele J Med Pediatr Oncol; 1994; 22(2):107-14. PubMed ID: 8259095 [TBL] [Abstract][Full Text] [Related]
2. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome. Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532 [TBL] [Abstract][Full Text] [Related]
3. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma. Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744 [TBL] [Abstract][Full Text] [Related]
4. Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring system. Suc A; Lumbroso J; Rubie H; Hattchouel JM; Boneu A; Rodary C; Robert A; Hartmann O Cancer; 1996 Feb; 77(4):805-11. PubMed ID: 8616776 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology. Hadj-Djilani NL; Lebtahi NE; Delaloye AB; Laurini R; Beck D Eur J Nucl Med; 1995 Apr; 22(4):322-9. PubMed ID: 7607262 [TBL] [Abstract][Full Text] [Related]
6. [Diagnostic and therapeutic possibilities of meta-iodobenzylguanidine in neuroblastoma]. Guerra P Pediatr Med Chir; 1990; 12(6):663-8. PubMed ID: 2093889 [TBL] [Abstract][Full Text] [Related]
7. Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma. Shulkin BL; Shen SW; Sisson JC; Shapiro B J Nucl Med; 1987 Mar; 28(3):315-8. PubMed ID: 3102702 [TBL] [Abstract][Full Text] [Related]
8. Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma. Katzenstein HM; Cohn SL; Shore RM; Bardo DM; Haut PR; Olszewski M; Schmoldt J; Liu D; Rademaker AW; Kletzel M J Clin Oncol; 2004 Oct; 22(19):3909-15. PubMed ID: 15459212 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy. Turba E; Fagioli G; Mancini AF; Rosito P; Galli A; Alvisi P J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456 [TBL] [Abstract][Full Text] [Related]
10. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?]. Sautter-Bihl ML; Bihl H; Heinze HG Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676 [TBL] [Abstract][Full Text] [Related]
12. The prognostic impact of functional imaging with (123)I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: results of the German Neuroblastoma Trial NB97. Schmidt M; Simon T; Hero B; Schicha H; Berthold F Eur J Cancer; 2008 Jul; 44(11):1552-8. PubMed ID: 18424129 [TBL] [Abstract][Full Text] [Related]
13. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma. Shulkin BL; Shapiro B; Hutchinson RJ J Nucl Med; 1992 Oct; 33(10):1735-40. PubMed ID: 1403138 [TBL] [Abstract][Full Text] [Related]
14. Metaiodobenzylguanidine assessment of metastatic neuroblastoma: observer dependency and chemosensitivity evaluation. The SFOP Group. Frappaz D; Bonneu A; Chauvot P; Edeline V; Giammarile F; Siles S; Wioland M; Gomez F Med Pediatr Oncol; 2000 Apr; 34(4):237-41. PubMed ID: 10742058 [TBL] [Abstract][Full Text] [Related]
15. Iodine-131-MIBG imaging to monitor chemotherapy response in advanced neuroblastoma: comparison with laboratory analysis. Maurea S; Lastoria S; Caracò C; Indolfi P; Casale F; di Tullio MT; Salvatore M J Nucl Med; 1994 Sep; 35(9):1429-35. PubMed ID: 8071687 [TBL] [Abstract][Full Text] [Related]
16. The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma. Andrich MP; Shalaby-Rana E; Movassaghi N; Majd M Pediatrics; 1996 Feb; 97(2):246-50. PubMed ID: 8584386 [TBL] [Abstract][Full Text] [Related]
17. A new 123I-MIBG whole body scan scoring method--application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastoma. Ady N; Zucker JM; Asselain B; Edeline V; Bonnin F; Michon J; Gongora R; Manil L Eur J Cancer; 1995; 31A(2):256-61. PubMed ID: 7718334 [TBL] [Abstract][Full Text] [Related]
18. Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases. Geatti O; Shapiro B; Sisson JC; Hutchinson RJ; Mallette S; Eyre P; Beierwaltes WH J Nucl Med; 1985 Jul; 26(7):736-42. PubMed ID: 4009283 [TBL] [Abstract][Full Text] [Related]
19. Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy. Voûte PA; Hoefnagel CA; de Kraker J; Valdes Olmos R; Bakker DJ; van de Kleij AJ Prog Clin Biol Res; 1991; 366():439-45. PubMed ID: 2068157 [No Abstract] [Full Text] [Related]
20. [Scintigraphic diagnosis of neuroblastoma using meta-iodobenzylguanidine]. Kimmig B; Brandeis WE; Eisenhut M; Ludwig R; Adolph J Klin Padiatr; 1986; 198(3):224-9. PubMed ID: 3723986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]